Conversion Price Cut 17% Expands Dilution to 23.3%... Lawsuit Risk Delays Issuance, Potential Control Change
PHIONX decided to issue 7 billion won worth of 31st series unsecured private convertible bonds, but due to a management dispute lawsuit (2026Kahap1239), the payment date has been postponed to June 18, 2026, and issuance is uncertain until the lawsuit is resolved.
The conversion price was lowered by 17% from 525 won to 436 won per share, increasing the number of shares to be issued upon conversion from 13.33 million to 16.06 million, raising the dilution ratio from 20.2% to 23.3% of total shares.
Including existing outstanding CBs (29th and 30th series), potential convertible shares total 24.09 million, representing 45.7% dilution relative to the current 52.76 million outstanding shares, severely impairing existing shareholder value.
The conversion price adjustment clause allows further downward adjustments to as low as 22 won based on market price declines, posing additional dilution risk if the stock price falls.
The issuance target is Meta77 Investment Association, which could become the largest shareholder if all conversion rights are exercised, indicating potential control change.
All 7 billion won of proceeds are intended for operating expenses (purchases, wages, new business), but specific business plans are still under review.
[AI Comprehensive Analysis]This disclosure contains multiple negative factors: increased dilution due to lower conversion price, issuance uncertainty from a lawsuit, and potential control change. These are expected to severely negatively impact shareholder value. Short-term downward price pressure is significant, with the lawsuit outcome and conversion exercise being key variables.
KOSDAQ Filing Information
Filing: [Correction of Description] Report on Major Matters (Decision on Issuance of Convertible Bonds)